Impact of oral anticoagulation on morbidity of transurethral resection of the prostate

World Journal of Urology

Volumn 29, Issue 2, 2011, Pages 211-216

  Descazeaud, Aurélien ^a,b,c   Robert, Gregoire ^c,d,e   Lebdai, Souhil ^f   Bougault, Alain ^a   Azzousi, Abdel Rahmene ^c,f   Haillot, Olivier ^c,g   Devonec, Marian ^c,h   Fourmarier, Marc ^c,i   Saussine, Christian ^c,j   Barry Delongchamps, Nicolas ^c,k   de la Taille, Alexandre ^c,d,l  

^a LIMOGES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY OF LIMOGES   (France)

^c Maison de l'urologie   (France)

^d INSERM   (France)

^e BORDEAUX UNIVERSITY HOSPITAL   (France)

^f ANGERS UNIVERSITY HOSPITAL   (France)

^g UNIVERSITY HOSPITAL OF TOURS   (France)

^h CENTRE HOSPITALIER LYON SUD   (France)

ⁱ CH ^*  (France)

^j UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^k CHU Cochin APHP ^*  (France)

^l HENRI MONDOR HOSPITAL   (France)

more..

Author keywords

Aspirin; BPH; Clopidogrel; Oral anticoagulation; TURP; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; WARFARIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; ERYTHROCYTE TRANSFUSION; HEMATURIA; HUMAN; LENGTH OF STAY; MALE; MIDDLE AGED; MORBIDITY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; THROMBOEMBOLISM; TRANSURETHRAL RESECTION;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ERYTHROCYTE TRANSFUSION; HEMATURIA; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MORBIDITY; PLATELET AGGREGATION INHIBITORS; THROMBOEMBOLISM; TRANSURETHRAL RESECTION OF PROSTATE; WARFARIN;

EID: 79953026037     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-010-0561-3     Document Type: Article

References (18)

1. Reich O, Gratzke C, Bachmann A et al (2008) Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10, 654 patients. J Urol 180: 246-249.
2. Borboroglu PG, Kane CJ, Ward JF, Roberts JL, Sands JP (1999) Immediate and postoperative complications of transurethral prostatectomy in the 1990 s. J Urol 162: 1307-1310.
3. Rassweiler J, Teber D, Kuntz R, Hofmann R (2006) Complications of transurethral resection of the prostate (TURP)-incidence, management, and prevention. Eur Urol 50: 969-979.
4. Kuntz RM (2007) Laser treatment of benign prostatic hyperplasia. World J Urol 25: 241-247.
5. Barmoshe S, Zlotta AR (2006) How do I treat and follow my TUNA patients. World J Urol 24: 397-404.
6. Herrmann TR, Gross AJ, Schultheiss D, Kaufmann PM, Jonas U, Burchardt M (2006) Transurethral microwave thermotherapy for the treatment of BPH: still a challenger? World J Urol 24: 389-396.
7. Descazeaud A, Robert G, Azzousi AR et al (2009) Committee for lower urinary tract symptoms of the French Association of Urology. Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy: a review. BJU Int 103: 1162-1165.
8. Ruszat R, Wyler S, Forster T et al (2007) Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol 51: 1031-1038.
9. Chakravarti A, Mawarfarinermott S (1998) Transurethral resection of the prostate in the anticoagulated patient. Br J Urol 81: 520-522.
10. Dotan ZA, Mor Y, Leibovitch I et al (2002) The efficacy and safety of perioperative low molecular weight heparin substitution in patients on chronic oral anticoagulant therapy undergoing transurethral prostatectomy for bladder outlet obstruction. J Urol 168: 610-613.
11. Parr NJ, Loh CS, Desmond AD (1989) Transurethral resection of the prostate and bladder tumour without withdrawal of warfarin therapy. Br J Urol 64: 623-625.
12. Burger W, Chemnitius JM, Kneissl GD, Rücker G (2005) Low-dose aspirin for secondary cardiovascular prevention-cardiovascular risks after its perioperative withdrawal vs. bleeding risks with its continuation-review and meta-analysis. J Intern Med 257: 399-414.
13. Nielsen JD, Holm-Nielsen A, Jespersen J, Vinther CC, Settgast IW, Gram J (2000) The effect of low-dose acetylsalicylic acid on bleeding after transurethral prostatectomy-a prospective, randomized, double-blind, placebo-controlled study. Scand J Urol Nephrol 34: 194-198.
14. Ruszat R, Wyler S, Forster T et al (2007) Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol 51: 1031-1038.
15. Ehrlich Y, Yossepowitch O, Margel D, Lask D, Livne PM, Baniel J (2007) Early initiation of aspirin after prostate and transurethral bladder surgeries is not associated with increased incidence of postoperative bleeding: a prospective, randomized trial. J Urol 178: 524-528.
16. Ten Cate H, Henny CP, ten Cate JW, Buller HR, Dabhoiwala NF (1987) Randomized double-blind, placebo controlled safety study of a low molecular weight heparinoid in patients under going transurethral resection of the prostate. Thromb Haemost 57: 92-96.
17. Lund L, Moller Ernst Jnsen K, Torring N, Erik Niesen J (2005) Impact of finasteride treatment on perioperative bleeding before transurethral resection of the prostate: a prospective randomized study. Scand J Urol Nephrol 39: 160-162.
18. Ozdal OL, Ozden C, Benli K, Gokkaya S, Bulut S, Memis A (2005) Effect of short term finasteride therapy on preoperative bleeding in patients who were candidates for transurethral resection of the prostate: a randomized controlled study. Prostate cancer Prostatic dis 8: 215-218.